Literature DB >> 6974111

The BB diabetic rat. Profound T-cell lymphocytopenia.

R Jackson, N Rassi, T Crump, B Haynes, G S Eisenbarth.   

Abstract

Approximately 50% of Wistar "BB" rats spontaneously develop overt diabetes mellitus characterized by loss of beta-cells and "insulitis." To define abnormalities of immunoregulation in these rats, we quantitated their major circulating lymphocyte subsets. Independent of the development of diabetes, we found the BB rats to have a markedly increased percentage of circulating B lymphocytes which is secondary to a severe T-cell lymphocytes which is secondary to a severe T-cell lymphocytopenia, with the major circulating T-cell subset reacting with monoclonal antibody W3/25 markedly decreased. This lymphocytopenia is present in every animal studied and contrasted with studies of the nondiabetic Wistar strain from which the "BB" rats were developed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6974111     DOI: 10.2337/diab.30.10.887

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  43 in total

1.  Elevated apoptosis of peripheral T lymphocytes in diabetic BB rats.

Authors:  C G Jung; T Kamiyama; T Agui
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  Cytotoxic T-cell precursors with low-level CD8 in the diabetes-prone Biobreeding rat: implications for generation of an autoimmune T-cell repertoire.

Authors:  D Bellgrau; A C Lagarde
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.

Authors:  V Ablamunits; D Elias; I R Cohen
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

4.  Resistance to tolerance induction in the diabetes-prone biobreeding rat as one manifestation of abnormal responses to superantigens.

Authors:  K S Sellins; D P Gold; D Bellgrau
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

5.  Neonatal development of lymphoid organs and specific immune responses in situ in diabetes-prone BB rats.

Authors:  E P van Rees; H A Voorbij; C D Dijkstra
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

6.  Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A.

Authors:  A A Like; V Dirodi; S Thomas; D L Guberski; A A Rossini
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

7.  Islet cell surface and lymphocyte antibodies often precede the spontaneous diabetes in the BB rat.

Authors:  T Dyrberg; P Poussier; F Nakhooda; E B Marliss; A Lernmark
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

8.  Changes in immune cell frequencies in primary and secondary lymphatic organs of LEW.1AR1-iddm rats, a model of human type 1 diabetes compared to other MHC congenic LEW inbred strains.

Authors:  Tanja Arndt; Anne Jörns; Dirk Wedekind
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

9.  Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat.

Authors:  A A Rossini; D Faustman; B A Woda; A A Like; I Szymanski; J P Mordes
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

Review 10.  The role of immunotherapy in type I diabetes mellitus.

Authors:  M E Geffner; B M Lippe
Journal:  West J Med       Date:  1987-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.